Company Filing History:
Years Active: 2011-2013
Title: Amie Deffenbaugh: Innovator in Genetic Research
Introduction
Amie Deffenbaugh is a prominent inventor based in Salt Lake City, Utah. She has made significant contributions to the field of genetics, particularly in the area of breast cancer research. With two patents to her name, her work has the potential to impact diagnostic practices in medicine.
Latest Patents
Amie Deffenbaugh's latest patents focus on genetic variants in the BRCA2 gene. These variants are disclosed as useful diagnostic biomarkers for breast cancer. Her patents, titled "Genetic variants in the BRCA2 gene are disclosed which are useful as diagnosis biomarkers" and "BRCA2 mutations and use thereof," highlight the importance of genetic testing in identifying individuals at risk for breast cancer.
Career Highlights
Amie is currently associated with Myriad Genetics, Inc., a leading company in genetic testing and personalized medicine. Her work at Myriad has allowed her to collaborate with other experts in the field and contribute to advancements in genetic research.
Collaborations
Some of her notable coworkers include Thomas M. Scholl and Brian E. Ward. Their collaborative efforts have furthered the understanding of genetic markers and their implications in cancer diagnosis.
Conclusion
Amie Deffenbaugh's innovative work in genetic research exemplifies the critical role of inventors in advancing medical science. Her contributions to the understanding of the BRCA2 gene are paving the way for improved diagnostic tools in the fight against breast cancer.